Pillar Pharmaceuticals I LP
CIK 0001534425 Name as filed on the most recent filing
Filed as Pillar Pharmaceuticals I LP (13)
66 transaction lines · from 13 filings · filed 2013-05-17 to 2020-02-26 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.
A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.
Issuers this insider has filed against
Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.
No issuer is recorded
The catalog holds no filing linking this CIK to an issuer.
Transactions
Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.
0 transactions · Newest transaction date first, id breaking the tie.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.
| Direction | Date | Issuer | Code | Shares | Price | Value USD | Filing |
|---|---|---|---|---|---|---|---|
| 2020-01-29 |
Idera Pharmaceuticals, Inc. IDRA |
S, Open-market sale | 17,250 disposed | 1.76 | 30,437.62 | Form 4, filing 0000899243-20-005917 | |
| 2020-01-28 |
Idera Pharmaceuticals, Inc. IDRA |
S, Open-market sale | 12,532 disposed | 1.76 | 22,081.38 | Form 4, filing 0000899243-20-005917 | |
| 2020-01-27 |
Idera Pharmaceuticals, Inc. IDRA |
S, Open-market sale | 15,000 disposed | 1.77 | 26,550.00 | Form 4, filing 0000899243-20-005917 | |
| 2019-11-08 |
Idera Pharmaceuticals, Inc. IDRA |
S, Open-market sale | 9,000 disposed | 2.44 | 21,960.00 | Form 4, filing 0000899243-19-027012 | |
| 2019-11-07 |
Idera Pharmaceuticals, Inc. IDRA |
S, Open-market sale | 10,000 disposed | 2.45 | 24,500.00 | Form 4, filing 0000899243-19-027012 | |
| 2019-11-06 |
Idera Pharmaceuticals, Inc. IDRA |
S, Open-market sale | 100,000 disposed | 2.50 | 249,560.00 | Form 4, filing 0000899243-19-027012 | |
| 2018-08-09 |
Idera Pharmaceuticals, Inc. IDRA |
S, Open-market sale | 25,000 disposed | 6.29 | 157,357.50 | Form 4, filing 0000899243-18-022726 | |
| 2018-08-09 |
Idera Pharmaceuticals, Inc. IDRA |
S, Open-market sale | 15,000 disposed | 6.35 | 95,323.50 | Form 4, filing 0000899243-18-022726 | |
| 2018-08-09 |
Idera Pharmaceuticals, Inc. IDRA |
S, Open-market sale | 15,000 disposed | 6.25 | 93,762.00 | Form 4, filing 0000899243-18-022726 | |
| 2018-08-08 |
Idera Pharmaceuticals, Inc. IDRA |
S, Open-market sale | 50,000 disposed | 5.88 | 294,190.00 | Form 4, filing 0000899243-18-022726 | |
| 2018-08-08 |
Idera Pharmaceuticals, Inc. IDRA |
S, Open-market sale | 20,000 disposed | 5.98 | 119,500.00 | Form 4, filing 0000899243-18-022726 | |
| 2018-08-08 |
Idera Pharmaceuticals, Inc. IDRA |
S, Open-market sale | 8,107 disposed | 5.89 | 47,759.15 | Form 4, filing 0000899243-18-022726 | |
| 2018-08-07 |
Idera Pharmaceuticals, Inc. IDRA |
S, Open-market sale | 91,893 disposed | 5.55 | 510,098.04 | Form 4, filing 0000899243-18-022726 | |
| 2018-08-07 |
Idera Pharmaceuticals, Inc. IDRA |
S, Open-market sale | 75,000 disposed | 5.62 | 421,717.50 | Form 4, filing 0000899243-18-022726 | |
| 2017-05-01 |
Idera Pharmaceuticals, Inc. IDRA |
S, Open-market sale | 409,237 disposed | 2.26 | 924,507.31 | Form 4, filing 0000899243-17-011717 | |
| 2017-05-01 |
Idera Pharmaceuticals, Inc. IDRA |
S, Open-market sale | 41,578 disposed | 2.26 | 93,928.86 | Form 4, filing 0000899243-17-011717 | |
| 2017-04-25 |
Idera Pharmaceuticals, Inc. IDRA |
S, Open-market sale | 890,593 disposed | 2.29 | 2,037,943.96 | Form 4, filing 0000899243-17-010925 | |
| 2017-04-24 |
Idera Pharmaceuticals, Inc. IDRA |
S, Open-market sale | 437,829 disposed | 2.29 | 1,002,059.23 | Form 4, filing 0000899243-17-010925 | |
| 2015-12-15 |
Idera Pharmaceuticals, Inc. IDRA |
S, Open-market sale | 77,587 disposed | Not reported | Not priced | Form 4, filing 0000899243-15-010065 | |
| 2015-12-15 |
Idera Pharmaceuticals, Inc. IDRA |
S, Open-market sale | 77,586 disposed | Not reported | Not priced | Form 4, filing 0000899243-15-010065 | |
| 2015-12-15 |
Idera Pharmaceuticals, Inc. IDRA |
S, Open-market sale | 77,586 disposed | Not reported | Not priced | Form 4, filing 0000899243-15-010065 | |
| 2015-12-14 |
Idera Pharmaceuticals, Inc. IDRA |
S, Open-market sale | 100,000 disposed | Not reported | Not priced | Form 4, filing 0000899243-15-009800 | |
| 2015-12-14 |
Idera Pharmaceuticals, Inc. IDRA |
S, Open-market sale | 100,000 disposed | Not reported | Not priced | Form 4, filing 0000899243-15-009800 | |
| 2015-12-14 |
Idera Pharmaceuticals, Inc. IDRA |
S, Open-market sale | 100,000 disposed | Not reported | Not priced | Form 4, filing 0000899243-15-009800 | |
| 2015-12-11 |
Idera Pharmaceuticals, Inc. IDRA |
S, Open-market sale | 770,155 disposed | Not reported | Not priced | Form 4, filing 0000899243-15-009800 | |
| 2015-12-11 |
Idera Pharmaceuticals, Inc. IDRA |
S, Open-market sale | 676,536 disposed | Not reported | Not priced | Form 4, filing 0000899243-15-009800 | |
| 2015-12-11 |
Idera Pharmaceuticals, Inc. IDRA |
S, Open-market sale | 676,535 disposed | Not reported | Not priced | Form 4, filing 0000899243-15-009800 | |
| 2015-12-11 |
Idera Pharmaceuticals, Inc. IDRA |
S, Open-market sale | 359,847 disposed | Not reported | Not priced | Form 4, filing 0000899243-15-009800 | |
| 2015-12-10 |
Idera Pharmaceuticals, Inc. IDRA |
S, Open-market sale | 25,591 disposed | Not reported | Not priced | Form 4, filing 0000899243-15-009800 | |
| 2015-12-10 |
Idera Pharmaceuticals, Inc. IDRA |
S, Open-market sale | 25,590 disposed | Not reported | Not priced | Form 4, filing 0000899243-15-009800 | |
| 2014-12-16 |
Idera Pharmaceuticals, Inc. IDRA |
S, Open-market sale | 339,018 disposed | Not reported | Not priced | Form 4, filing 0001209191-14-075984 | |
| 2014-12-16 |
Idera Pharmaceuticals, Inc. IDRA |
S, Open-market sale | 93,230 disposed | Not reported | Not priced | Form 4, filing 0001209191-14-075984 | |
| 2014-12-16 |
Idera Pharmaceuticals, Inc. IDRA |
S, Open-market sale | 67,804 disposed | Not reported | Not priced | Form 4, filing 0001209191-14-075984 | |
| 2014-12-16 |
Idera Pharmaceuticals, Inc. IDRA |
S, Open-market sale | 50,853 disposed | Not reported | Not priced | Form 4, filing 0001209191-14-075984 | |
| 2014-12-15 |
Idera Pharmaceuticals, Inc. IDRA |
S, Open-market sale | 178,462 disposed | Not reported | Not priced | Form 4, filing 0001209191-14-075984 | |
| 2014-12-15 |
Idera Pharmaceuticals, Inc. IDRA |
S, Open-market sale | 49,077 disposed | Not reported | Not priced | Form 4, filing 0001209191-14-075984 | |
| 2014-12-15 |
Idera Pharmaceuticals, Inc. IDRA |
S, Open-market sale | 35,692 disposed | Not reported | Not priced | Form 4, filing 0001209191-14-075984 | |
| 2014-12-15 |
Idera Pharmaceuticals, Inc. IDRA |
S, Open-market sale | 26,769 disposed | Not reported | Not priced | Form 4, filing 0001209191-14-075984 | |
| 2014-12-12 |
Idera Pharmaceuticals, Inc. IDRA |
S, Open-market sale | 160,521 disposed | Not reported | Not priced | Form 4, filing 0001209191-14-075984 | |
| 2014-12-12 |
Idera Pharmaceuticals, Inc. IDRA |
S, Open-market sale | 44,143 disposed | Not reported | Not priced | Form 4, filing 0001209191-14-075984 | |
| 2014-12-12 |
Idera Pharmaceuticals, Inc. IDRA |
S, Open-market sale | 32,104 disposed | Not reported | Not priced | Form 4, filing 0001209191-14-075984 | |
| 2014-12-12 |
Idera Pharmaceuticals, Inc. IDRA |
S, Open-market sale | 24,078 disposed | Not reported | Not priced | Form 4, filing 0001209191-14-075984 | |
| 2014-12-11 |
Idera Pharmaceuticals, Inc. IDRA |
S, Open-market sale | 438,836 disposed | Not reported | Not priced | Form 4, filing 0001209191-14-074765 | |
| 2014-12-11 |
Idera Pharmaceuticals, Inc. IDRA |
S, Open-market sale | 120,680 disposed | Not reported | Not priced | Form 4, filing 0001209191-14-074765 | |
| 2014-12-11 |
Idera Pharmaceuticals, Inc. IDRA |
S, Open-market sale | 87,767 disposed | Not reported | Not priced | Form 4, filing 0001209191-14-074765 | |
| 2014-12-11 |
Idera Pharmaceuticals, Inc. IDRA |
S, Open-market sale | 65,825 disposed | Not reported | Not priced | Form 4, filing 0001209191-14-074765 | |
| 2014-12-10 |
Idera Pharmaceuticals, Inc. IDRA |
S, Open-market sale | 216,028 disposed | Not reported | Not priced | Form 4, filing 0001209191-14-074765 | |
| 2014-12-10 |
Idera Pharmaceuticals, Inc. IDRA |
S, Open-market sale | 59,408 disposed | Not reported | Not priced | Form 4, filing 0001209191-14-074765 | |
| 2014-12-10 |
Idera Pharmaceuticals, Inc. IDRA |
S, Open-market sale | 43,206 disposed | Not reported | Not priced | Form 4, filing 0001209191-14-074765 | |
| 2014-12-10 |
Idera Pharmaceuticals, Inc. IDRA |
S, Open-market sale | 32,404 disposed | Not reported | Not priced | Form 4, filing 0001209191-14-074765 |
This column is intentionally blank
No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.
- S, Open-market sale
- Open-market sale
Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.
What this insider's stored lines contain
No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.
How to cite this page
ebomi catalog. Pillar Pharmaceuticals I LP, insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001534425
Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6